U.S. Hemostasis & Tissue Sealing Agents Market Size & Outlook

The hemostasis & tissue sealing agents market in the United States is expected to reach a projected revenue of US$ 3,010.5 million by 2030. A compound annual growth rate of 4% is expected of the United States hemostasis & tissue sealing agents market from 2024 to 2030.
Revenue, 2023 (US$M)
$2,286.9
Forecast, 2030 (US$M)
$3,010.5
CAGR, 2024 - 2030
4%
Report Coverage
U.S.

U.S. hemostasis & tissue sealing agents market, 2018-2030 (US$M)

U.S.

Related Markets

U.S. hemostasis & tissue sealing agents market highlights

  • The U.S. hemostasis & tissue sealing agents market generated a revenue of USD 2,286.9 million in 2023 and is expected to reach USD 3,010.5 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 4% from 2024 to 2030.
  • In terms of segment, topical hemostat was the largest revenue generating product in 2023.
  • Adhesive & tissue sealant is the most lucrative product segment registering the fastest growth during the forecast period.


Hemostasis & tissue sealing agents market data book summary

Market revenue in 2023USD 2,286.9 million
Market revenue in 2030USD 3,010.5 million
Growth rate4% (CAGR from 2023 to 2030)
Largest segmentTopical hemostat
Fastest growing segmentAdhesive & tissue sealant
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationTopical hemostat, Adhesive & tissue sealant
Key market players worldwideJohnson & Johnson, Cryolife, Cohera Medical, Pfizer Inc, Becton Dickinson & Co, Baxter International Inc, HyperBranch Medical Technology, Zimmer Biomet Holdings Inc, B. Braun Medical, Smith & Nephew PLC, Advanced Medical Solutions, Integra Lifesciences Holdings Corp


Other key industry trends

  • In terms of revenue, U.S. accounted for 28.6% of the global hemostasis & tissue sealing agents market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. hemostasis & tissue sealing agents market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 576.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Hemostasis & Tissue Sealing Agents Market Companies

Name Profile # Employees HQ Website

U.S. hemostasis & tissue sealing agents market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hemostasis & tissue sealing agents market will help companies and investors design strategic landscapes.


Topical hemostat was the largest segment with a revenue share of 65.78% in 2023. Horizon Databook has segmented the U.S. hemostasis & tissue sealing agents market based on topical hemostat, adhesive & tissue sealant covering the revenue growth of each sub-segment from 2018 to 2030.


The U.S. hemostasis and tissue sealing agents market is expected to grow rapidly by 2025. Drivers responsible for growth are increasing obese & geriatric population and growing demand for sealants to avoid postoperative risk of bleeding. 

Moreover, interest of market players is growing in the underpenetrated hemostasis and tissue sealing agents market, which is driving innovation and development of new products in this market. Multifunctional products such as fibrin products, which offer both tissue sealing and hemostatic properties, are expected to witness high demand in this market. 

Ethicon and Baxter are two companies that provide such products. However, the FDA approval process to gain approval for such devices in the U.S is strict. For instance, Oxiplex Gel Adhesion Barrier by FzioMed is available in over 70 countries, but is yet to be approved by the U.S. FDA. 

Reasons to subscribe to U.S. hemostasis & tissue sealing agents market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. hemostasis & tissue sealing agents market databook

  • Our clientele includes a mix of hemostasis & tissue sealing agents market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. hemostasis & tissue sealing agents market , including forecasts for subscribers. This country databook contains high-level insights into U.S. hemostasis & tissue sealing agents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. hemostasis & tissue sealing agents market size, by product, 2018-2030 (US$M)

U.S. Hemostasis & Tissue Sealing Agents Market Outlook Share, 2023 & 2030 (US$M)

U.S. hemostasis & tissue sealing agents market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more